H. Fujinaga et al., Electrophysiologic effects of quinaprilat in dogs during acute myocardial ischemia and following reperfusion, CORON ART D, 9(10), 1998, pp. 697-701
Background There have been few studies concerning the electrophysiologic ch
anges associated with the use of angiotensin-converting enzyme inhibitors i
n patients with acute myocardial infarction. We examined the electrophysiol
ogic effects of quinaprilat in dogs during acute myocardial ischemia and fo
llowing reperfusion,
Methods The left anterior descending coronary artery was occluded for 10 mi
n and reperfused for 10 min. Animals received intravenous quinaprilat (3 mu
g/kg per min, quinaprilat group) or saline (control group). We measured th
e ventricular effective refractory period and intra-myocardial conduction t
ime within the left anterior descending coronary artery region (ischemic re
gion) during myocardial ischemia and following reperfusion, and determined
the frequency of ventricular fibrillation,
Results The effective refractory period in the ischemic region decreased du
ring myocardial ischemia, and decreased further immediately after reperfusi
on in the control group. The intra-myocardial conduction time in the ischem
ic region increased during myocardial ischemia but rapidly shortened after
reperfusion in the control group. In the quinaprilat group, however, no sig
nificant differences were evident between the ischemic and non-ischemic reg
ions in either the effective refractory period or the intra-myocardial cond
uction time during myocardial ischemia or following reperfusion. The percen
tage shortening of the effective refractory period and the percentage prolo
ngation of the intra-myocardial conduction time in the ischemic region were
significantly lower in the quinaprilat group than in the control group dur
ing myocardial ischemia and following reperfusion. The frequency of ventric
ular fibrillation during myocardial ischemia and following reperfusion was
significantly lower in the quinaprilat group (21%) than in the control grou
p (74%; P < 0.01).
Conclusions Quinaprilat protects against electrophysiologic abnormalities,
and may decrease arrhythmias during acute myocardial ischemia and following
reperfusion. Coronary Artery Dis 9:697-701 (C) 1998 Lippincott Williams &
Wilkins.